Anti-TNF compounds
US10760080B2 · kind B2 · utility
5Cited by
23References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 2019 |
| Grant date | Sep 1, 2020 |
| Priority date | — |
| Expiry date | Jan 16, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
TNFα antisense oligonucleotides are provided herein. Methods of treating TNFα diseases or Initial Screen of Phosphodiester disorders using the TNFα antisense oligonucleotides and related products are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.